Literature DB >> 34796748

Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrier.

Ariel Diaz1, Yena Woo1, Cynthia Martin-Jimenez1, Paola Merino1, Enrique Torre1, Manuel Yepes1,2,3.   

Abstract

Ischemic tolerance is a phenomenon whereby transient exposure to a non-injurious preconditioning stimulus triggers resistance to a subsequent lethal ischemic insult. Despite the fact that not only neurons but also astrocytes and endothelial cells have a unique response to preconditioning stimuli, current research has been focused mostly on the effect of preconditioning on neuronal death. Thus, it is unclear if the blood-brain barrier (BBB) can be preconditioned independently of an effect on neuronal survival. The release of tissue-type plasminogen activator (tPA) from perivascular astrocytes in response to an ischemic insult increases the permeability of the BBB. In line with these observations, treatment with recombinant tPA increases the permeability of the BBB and genetic deficiency of tPA attenuates the development of post-ischemic edema. Here we show that tPA induces ischemic tolerance in the BBB independently of an effect on neuronal survival. We found that tPA renders the BBB resistant to an ischemic injury by inducing TNF-α-mediated astrocytic activation and increasing the abundance of aquaporin-4-immunoreactive astrocytic end-feet processes in the neurovascular unit. This is a new role for tPA, that does not require plasmin generation, and with potential therapeutic implications for patients with cerebrovascular disease.

Entities:  

Keywords:  Cerebral ischemia; blood-brain barrier; plasmin; preconditioning; tissue-type plasminogen activator

Mesh:

Substances:

Year:  2021        PMID: 34796748      PMCID: PMC9051146          DOI: 10.1177/0271678X211060395

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.960


  58 in total

Review 1.  The plasminogen (fibrinolytic) system.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.

Authors:  Rohini Polavarapu; Maria Carolina Gongora; Hong Yi; Sripriya Ranganthan; Daniel A Lawrence; Dudley Strickland; Manuel Yepes
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

3.  Autonomous functions of structural domains on human tissue-type plasminogen activator.

Authors:  A J van Zonneveld; H Veerman; H Pannekoek
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats.

Authors:  K Tasaki; C A Ruetzler; T Ohtsuki; D Martin; H Nawashiro; J M Hallenbeck
Journal:  Brain Res       Date:  1997-02-14       Impact factor: 3.252

5.  Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation.

Authors:  Rohini Polavarapu; Maria Carolina Gongora; Jeffrey A Winkles; Manuel Yepes
Journal:  J Neurosci       Date:  2005-11-02       Impact factor: 6.167

6.  Glial cells drive preconditioning-induced blood-brain barrier protection.

Authors:  Raffaella Gesuete; Franca Orsini; Elisa R Zanier; Diego Albani; Maria A Deli; Gianfranco Bazzoni; Maria-Grazia De Simoni
Journal:  Stroke       Date:  2011-04-07       Impact factor: 7.914

7.  Protective role of early aquaporin 4 induction against postischemic edema formation.

Authors:  Lorenz Hirt; Béatrice Ternon; Melanie Price; Nabil Mastour; Jean-François Brunet; Jérôme Badaut
Journal:  J Cereb Blood Flow Metab       Date:  2008-11-05       Impact factor: 6.200

Review 8.  Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

Authors:  Manuel Yepes; Benoit D Roussel; Carine Ali; Denis Vivien
Journal:  Trends Neurosci       Date:  2008-10-27       Impact factor: 13.837

9.  Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.

Authors:  Ariel Diaz; Paola Merino; Luis G Manrique; Lihong Cheng; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-12       Impact factor: 6.200

10.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.

Authors:  Nathalie Percie du Sert; Viki Hurst; Amrita Ahluwalia; Sabina Alam; Marc T Avey; Monya Baker; William J Browne; Alejandra Clark; Innes C Cuthill; Ulrich Dirnagl; Michael Emerson; Paul Garner; Stephen T Holgate; David W Howells; Natasha A Karp; Stanley E Lazic; Katie Lidster; Catriona J MacCallum; Malcolm Macleod; Esther J Pearl; Ole H Petersen; Frances Rawle; Penny Reynolds; Kieron Rooney; Emily S Sena; Shai D Silberberg; Thomas Steckler; Hanno Würbel
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-14       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.